Twenty-nine opioid-exposed and 26 nonopioid-exposed neonates received neonatal
abstinence syndrome (NAS) assessment by an examiner blinded to group status twice daily …

In a number of countries, the prevalence of neonatal opioid withdrawal syndrome (NOWS) is
increasing. While NOWS is ultimately the result of opioid exposure in utero, a wide range of …

Buprenorphine is the preferred treatment of opioid use disorder during pregnancy but can
cause fetal opioid dependence and neonatal opioid withdrawal syndrome (NOWS). Notably …

Maternal opioid use during pregnancy is a growing national problem and can lead to
newborns developing neonatal opioid withdrawal syndrome (NOWS) soon after birth …

Objective To examine the therapeutic potential of stochastic vibrotactile stimulation (SVS) as
a complementary non-pharmacological intervention for withdrawal in opioid-exposed …

BACKGROUND: Prior studies have shown an increased vulnerability among males to
adverse outcomes during the postnatal period. Most children exposed to opioids and other …

Background: The majority of women who are pregnant with opioid use disorder (OUD) also
smoke tobacco but are rarely offered tobacco cessation counseling. While the effects of …

Opioid use during pregnancy has serious consequences for mother and baby. The true
extent of the problem is unknown and there is a need for better screening. Existing …

Aim: To determine whether infant gender influences the course of neonatal abstinence
syndrome (NAS) following exposure to buprenorphine during pregnancy. Methods: A …

The opioid crisis affects pregnant women and their infants. In the past two decades, the
number of infants born with neonatal abstinence syndrome (NAS) has quadrupled causing …